Irbesartan
Product Images NDC 68180-410

6 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 68180-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (9e1f14f9 Dbd8 4946 880a 144baa019ace 01)

Image 1 (9e1f14f9 Dbd8 4946 880a 144baa019ace 01)
Chemical structure of the active ingredient irbesartan, showing the arrangement of its atoms and rings as depicted in the molecular diagram.*
FDA Label Image

Image 2 (9e1f14f9 Dbd8 4946 880a 144baa019ace 02)

Image 2 (9e1f14f9 Dbd8 4946 880a 144baa019ace 02)
Two scatter plots showing placebo-subtracted reductions in blood pressure with various doses of Irbesartan. The left graph depicts the reduction in trough systolic blood pressure (SeSBP) in mmHg versus Irbesartan dose (mg/day). The right graph shows the reduction in trough diastolic blood pressure (SeDBP) in mmHg versus Irbesartan dose (mg/day). Both include dose-response curves based on an integrated analysis.*
FDA Label Image

Image 3 (9e1f14f9 Dbd8 4946 880a 144baa019ace 03)

Image 3 (9e1f14f9 Dbd8 4946 880a 144baa019ace 03)
A line graph showing cumulative event rate (%) over months of follow-up (0 to 60) for three groups: Irbesartan, Amlodipine, and Placebo. The graph compares the progression of event rates, with Irbesartan and Amlodipine following similar but generally lower event rates compared to Placebo. A legend box includes relative risk (RR) values and p-values comparing Irbesartan versus Placebo and Irbesartan versus Amlodipine.*
FDA Label Image

Image 4 (9e1f14f9 Dbd8 4946 880a 144baa019ace 04)

Image 4 (9e1f14f9 Dbd8 4946 880a 144baa019ace 04)
Label for Irbesartan Tablets USP 75 mg by Lupin Pharmaceuticals, Inc. The label indicates each tablet contains 75 mg of irbesartan and that the package contains 30 tablets. Storage instructions specify keeping the product at 25°C with permitted excursions. Manufacturing information includes Lupin Pharmaceuticals, Inc. in Baltimore, MD, and Lupin Limited in India. Includes barcode and standard drug storage instructions.*
FDA Label Image

Image 5 (9e1f14f9 Dbd8 4946 880a 144baa019ace 05)

Image 5 (9e1f14f9 Dbd8 4946 880a 144baa019ace 05)
Label for Irbesartan Tablets USP 150 mg by Lupin Pharmaceuticals, Inc. The label indicates each tablet contains 150 mg of irbesartan. It includes storage instructions and manufacturer information for Lupin Pharmaceuticals in the USA and Lupin Limited in India. The package contains 30 tablets.*
FDA Label Image

Image 6 (9e1f14f9 Dbd8 4946 880a 144baa019ace 06)

Image 6 (9e1f14f9 Dbd8 4946 880a 144baa019ace 06)
Label for Irbesartan Tablets USP 300 mg by Lupin Pharmaceuticals, Inc. The label specifies each tablet contains 300 mg of irbesartan, is Rx only, and the package contains 30 tablets. It includes storage instructions and manufacturing information for Lupin Pharmaceuticals and Lupin Limited, India. The label also displays the NDC and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.